
Sign up to save your podcasts
Or


In this episode, Kyle interviews Juan Pablo Cappello: co-founder and former CEO of Nue Life Health, whose assets were subsequently acquired by Beckley Waves.
Cappello discusses the current challenges and controversies facing a ketamine industry that has moved much faster than anyone anticipated, and stresses the need to create industry-wide standards – especially for at-home ketamine – before the government imposes its own standards on us. Citing the Matthew Perry case and other bad behavior from providers, he talks about the risks of overpromising and underdelivering, the lack of integration in the majority of at-home ketamine frameworks, and how profit-driven, subscription model motives have overshadowed patient care and ethical practices.
He also discusses:
and more!
For links, head to the show notes page.
By Psychedelics Today4.6
553553 ratings
In this episode, Kyle interviews Juan Pablo Cappello: co-founder and former CEO of Nue Life Health, whose assets were subsequently acquired by Beckley Waves.
Cappello discusses the current challenges and controversies facing a ketamine industry that has moved much faster than anyone anticipated, and stresses the need to create industry-wide standards – especially for at-home ketamine – before the government imposes its own standards on us. Citing the Matthew Perry case and other bad behavior from providers, he talks about the risks of overpromising and underdelivering, the lack of integration in the majority of at-home ketamine frameworks, and how profit-driven, subscription model motives have overshadowed patient care and ethical practices.
He also discusses:
and more!
For links, head to the show notes page.

819 Listeners

1,846 Listeners

2,635 Listeners

1,479 Listeners

633 Listeners

1,287 Listeners

1,012 Listeners

309 Listeners

1,047 Listeners

470 Listeners

184 Listeners

280 Listeners

114 Listeners

115 Listeners

149 Listeners